Experimental and emerging therapies for sepsis and septic shock.
about
Translational systems biology of inflammation: potential applications to personalized medicine.LL-37 protects rats against lethal sepsis caused by gram-negative bacteriaCytokine modulation in sepsis and septic shock.Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens.Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock.
P2860
Experimental and emerging therapies for sepsis and septic shock.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Experimental and emerging therapies for sepsis and septic shock.
@ast
Experimental and emerging therapies for sepsis and septic shock.
@en
Experimental and emerging therapies for sepsis and septic shock.
@nl
type
label
Experimental and emerging therapies for sepsis and septic shock.
@ast
Experimental and emerging therapies for sepsis and septic shock.
@en
Experimental and emerging therapies for sepsis and septic shock.
@nl
prefLabel
Experimental and emerging therapies for sepsis and septic shock.
@ast
Experimental and emerging therapies for sepsis and septic shock.
@en
Experimental and emerging therapies for sepsis and septic shock.
@nl
P2860
P1476
Experimental and emerging therapies for sepsis and septic shock.
@en
P2860
P304
P356
10.1517/13543784.10.8.1471
P407
P577
2001-08-01T00:00:00Z